nach oben

Cancer and Metastasis Reviews

Erschienen in:

12.11.2016

Cancer-derived extracellular vesicles: the ‘soil conditioner’ in breast cancer metastasis?

verfasst von: Andrew R. Chin, Shizhen Emily Wang

Erschienen in: Cancer and Metastasis Reviews | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

It has been recognized that cancer-associated mortality is more often a result of the disrupted physiological functions in multiple organs following metastatic dissemination of cancer cells, rather than the presence and growth of the primary tumor. Despite advances in our understanding of the events leading to cancer initiation, growth, and acquisition of invasive properties, we are still unable to effectively treat metastatic disease. It is now being accepted that the secretion of extracellular vesicles, such as exosomes from cancer cells, has a profound impact on the initiation and propagation of metastatic breast cancer. These cancer-secreted vesicles differ from other means of cellular communication due to their capability of bulk delivery and organotropism. Here, we provide an overview of the role of extracellular vesicles in breast cancer metastasis and discuss key areas that may facilitate our understanding of metastatic breast cancer to guide our efforts towards providing better therapies.

Villarroya-Beltri, C., Baixauli, F., et al. (2014). Sorting it out: regulation of exosome loading. Seminars in Cancer Biology , 28, 3–13.CrossRefPubMedPubMedCentral

Hoshino, A., Costa-Silva, B., et al. (2015). Tumour exosome integrins determine organotropic metastasis. Nature , 527(7578), 329–335.CrossRefPubMedPubMedCentral

Harris, D. A., Patel, S. H., et al. (2015). Exosomes released from breast cancer carcinomas stimulate cell movement. PloS One , 10(3), e0117495.CrossRefPubMedPubMedCentral

McCready, J., Sims, J. D., et al. (2010). Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer , 10, 294.CrossRefPubMedPubMedCentral

Melo, S. A., Sugimoto, H., et al. (2014). Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell , 26(5), 707–721.CrossRefPubMedPubMedCentral

O'Brien, K., Rani, S., et al. (2013). Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells. European Journal of Cancer , 49(8), 1845–1859.CrossRefPubMed

Singh, R., Pochampally, R., et al. (2014). Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Molecular Cancer , 13, 256.CrossRefPubMedPubMedCentral

Le, M. T., Hamar, P., et al. (2014). miR-200-containing extracellular vesicles promote breast cancer cell metastasis. The Journal of Clinical Investigation , 124(12), 5109–5128.CrossRefPubMedPubMedCentral

Smith, Z. J., Lee, C., et al. (2015). Single exosome study reveals subpopulations distributed among cell lines with variability related to membrane content. J Extracell Vesicles , 4, 28533.CrossRefPubMed

10.

Su, J. (2015). Label-free single molecule detection using Microtoroid optical resonators. Journal of Visualized Experiments , 106, e53180.

11.

Tauro, B. J., Greening, D. W., et al. (2013a). Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Molecular & Cellular Proteomics , 12(3), 587–598.CrossRef

12.

Willms, E., Johansson, H. J., et al. (2016). Cells release subpopulations of exosomes with distinct molecular and biological properties. Scientific Reports , 6, 22519.CrossRefPubMedPubMedCentral

13.

Koumangoye, R. B., Sakwe, A. M., et al. (2011). Detachment of breast tumor cells induces rapid secretion of exosomes which subsequently mediate cellular adhesion and spreading. PloS One , 6(9), e24234.CrossRefPubMedPubMedCentral

14.

Sung, B. H., Ketova, T., et al. (2015). Directional cell movement through tissues is controlled by exosome secretion. Nature Communications , 6, 7164.CrossRefPubMedPubMedCentral

15.

Hoshino, D., Kirkbride, K. C., et al. (2013). Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Reports , 5(5), 1159–1168.CrossRefPubMed

16.

Purushothaman, A., Bandari, S. K., et al. (2016). Fibronectin on the surface of myeloma cell-derived exosomes mediates exosome-cell interactions. The Journal of Biological Chemistry , 291(4), 1652–1663.CrossRefPubMed

17.

Cho, J. A., Park, H., et al. (2012). Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells. International Journal of Oncology , 40(1), 130–138.PubMed

18.

Luga, V., Zhang, L., et al. (2012). Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell , 151(7), 1542–1556.CrossRefPubMed

19.

Dutta, S., Warshall, C., et al. (2014). Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells. PloS One , 9(5), e97580.CrossRefPubMedPubMedCentral

20.

Yang, M., Chen, J., et al. (2011). Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Molecular Cancer , 10, 117.CrossRefPubMedPubMedCentral

21.

Seubert, B., Grunwald, B., et al. (2015). Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice. Hepatology , 61(1), 238–248.CrossRefPubMed

22.

Skog, J., Wurdinger, T., et al. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nature Cell Biology , 10(12), 1470–1476.CrossRefPubMedPubMedCentral

23.

Jung, K. K., Liu, X. W., et al. (2006). Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. The EMBO Journal , 25(17), 3934–3942.CrossRefPubMedPubMedCentral

24.

Zhou, W., Fong, M. Y., et al. (2014). Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell , 25(4), 501–515.CrossRefPubMedPubMedCentral

25.

Tominaga, N., Kosaka, N., et al. (2015). Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nature Communications , 6, 6716.CrossRefPubMedPubMedCentral

26.

Fong, M. Y., Zhou, W., et al. (2015). Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nature Cell Biology , 17(2), 183–194.CrossRefPubMedPubMedCentral

27.

Zhang, L., Zhang, S., et al. (2015). Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature , 527(7576), 100–104.CrossRefPubMedPubMedCentral

28.

Xiang, X., Poliakov, A., et al. (2009). Induction of myeloid-derived suppressor cells by tumor exosomes. International Journal of Cancer , 124(11), 2621–2633.CrossRefPubMedPubMedCentral

29.

Chow, A., Zhou, W., et al. (2014). Macrophage immunomodulation by breast cancer-derived exosomes requires toll-like receptor 2-mediated activation of NF-kappaB. Scientific Reports , 4, 5750.CrossRefPubMedPubMedCentral

30.

Yu, S., Liu, C., et al. (2007). Tumor exosomes inhibit differentiation of bone marrow dendritic cells. Journal of Immunology , 178(11), 6867–6875.CrossRef

31.

Clayton, A., Al-Taei, S., et al. (2011). Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. Journal of Immunology , 187(2), 676–683.CrossRef

32.

Liu, C., Yu, S., et al. (2006). Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. Journal of Immunology , 176(3), 1375–1385.CrossRef

33.

Kosaka, N., Iguchi, H., et al. (2013). Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. The Journal of Biological Chemistry , 288(15), 10849–10859.CrossRefPubMedPubMedCentral

34.

Cogolludo, A., Moreno, L., et al. (2009). Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction. Cardiovascular Research , 82(2), 296–302.CrossRefPubMed

35.

King, H. W., Michael, M. Z., et al. (2012). Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer , 12, 421.CrossRefPubMedPubMedCentral

36.

Wilson, W. R., & Hay, M. P. (2011). Targeting hypoxia in cancer therapy. Nature Reviews. Cancer , 11(6), 393–410.CrossRefPubMed

37.

Zhao, H., Yang, L., et al. (2016). Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. eLife , 5, e10250.PubMedPubMedCentral

38.

Wang, T., Gilkes, D. M., et al. (2014). Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis. Proceedings of the National Academy of Sciences of the United States of America , 111(31), E3234–E3242.CrossRefPubMedPubMedCentral

39.

Parolini, I., Federici, C., et al. (2009). Microenvironmental pH is a key factor for exosome traffic in tumor cells. The Journal of Biological Chemistry , 284(49), 34211–34222.CrossRefPubMedPubMedCentral

40.

Ban, J. J., Lee, M., et al. (2015). Low pH increases the yield of exosome isolation. Biochemical and Biophysical Research Communications , 461(1), 76–79.CrossRefPubMed

41.

Ostrowski, M., Carmo, N. B., et al. (2010). Rab27a and Rab27b control different steps of the exosome secretion pathway. Nature Cell Biology , 12(1), 19–30 sup pp 11-13.CrossRefPubMed

42.

Bobrie, A., Krumeich, S., et al. (2012). Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Research , 72(19), 4920–4930.CrossRefPubMed

43.

Hendrix, A., Sormunen, R., et al. (2013). Vacuolar H+ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer. International Journal of Cancer , 133(4), 843–854.CrossRefPubMed

44.

Zhang, J. X., Huang, X. X., et al. (2012). Overexpression of the secretory small GTPase Rab27B in human breast cancer correlates closely with lymph node metastasis and predicts poor prognosis. Journal of Translational Medicine , 10, 242.CrossRefPubMedPubMedCentral

45.

Tauro, B. J., Mathias, R. A., et al. (2013b). Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK)cell-derived exosomal proteins following epithelial-mesenchymal transition. Molecular & Cellular Proteomics , 12(8), 2148–2159.

46.

Garnier, D., Magnus, N., et al. (2012). Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor. The Journal of Biological Chemistry , 287(52), 43565–43572.CrossRefPubMedPubMedCentral

47.

Gopal, S. K., Greening, D. W., et al. (2016). Oncogenic epithelial cell-derived exosomes containing Rac1 and PAK2 induce angiogenesis in recipient endothelial cells. Oncotarget , 7, 19709–19722.PubMedPubMedCentral

48.

Thompson, C. A., Purushothaman, A., et al. (2013). Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. The Journal of Biological Chemistry , 288(14), 10093–10099.CrossRefPubMedPubMedCentral

49.

Hendrix, A., Maynard, D., et al. (2010). Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis. Journal of the National Cancer Institute , 102(12), 866–880.CrossRefPubMedPubMedCentral

50.

Peinado, H., Aleckovic, M., et al. (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nature Medicine , 18(6), 883–891.CrossRefPubMedPubMedCentral

51.

Admyre, C., Johansson, S. M., et al. (2007). Exosomes with immune modulatory features are present in human breast milk. Journal of Immunology , 179(3), 1969–1978.CrossRef

52.

Bissell, M. J., & Hines, W. C. (2011). Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nature Medicine , 17(3), 320–329.CrossRefPubMedPubMedCentral

53.

Lim, P. K., Bliss, S. A., et al. (2011). Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Research , 71(5), 1550–1560.CrossRefPubMed

54.

Ono, M., Kosaka, N., et al. (2014). Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Science Signaling , 7(332), ra63.CrossRefPubMed

Titel: Cancer-derived extracellular vesicles: the ‘soil conditioner’ in breast cancer metastasis?
verfasst von: Andrew R. Chin
Shizhen Emily Wang
Publikationsdatum: 12.11.2016
Verlag: Springer US
Erschienen in: Cancer and Metastasis Reviews / Ausgabe 4/2016
Print ISSN: 0167-7659
Elektronische ISSN: 1573-7233
DOI: https://doi.org/10.1007/s10555-016-9639-8

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Cancer-derived extracellular vesicles: the ‘soil conditioner’ in breast cancer metastasis?

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2016

Advances in decoding breast cancer brain metastasis

EMT, cell plasticity and metastasis

Patient-derived xenograft (PDX) models in basic and translational breast cancer research

Current challenges of metastatic breast cancer

The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer

Preface

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie